|
51 |
Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
Enthalten in BMC endocrine disorders Bd. 18, 26.11.2018, Nr. 1, date:12.2018: 1-10
|
|
|
|
52 |
Trial of Optimal Personalised Care After Treatment for Gynaecological cancer (TOPCAT-G): a study protocol for a randomised feasibility trial
Enthalten in Pilot and feasibility studies Bd. 2, 23.11.2016, Nr. 1, date:12.2016: 1-11
|
|
|
|
53 |
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres
Enthalten in European journal of human genetics Bd. 32, 14.10.2024, Nr. 12, date:12.2024: 1632-1639
|
|
|
|
54 |
Using the nominal group technique to involve young people in an evidence synthesis which explored ‘risk’ in inpatient mental healthcare
Enthalten in Research involvement and engagement Bd. 3, 1.9.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
55 |
X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by androgen response elements
Enthalten in Nature Communications Bd. 15, 18.1.2024, Nr. 1, date:12.2024: 1-17
|
|
Administration
